Mean Arterial Pressure (MAP) Was the Primary Hemodynamic Objective
The most recent high-quality evidence demonstrates that mean arterial pressure (MAP) served as the primary intraoperative hemodynamic parameter in adult ASA I-III patients undergoing elective surgery, with specific target thresholds being the focus of optimization strategies.
MAP as the Central Hemodynamic Target
The contemporary evidence consistently identifies MAP as the primary objective for intraoperative hemodynamic management:
The HISTAP trial 1 directly compared MAP targets of ≥80 mmHg versus ≥65 mmHg in hypertensive high-risk patients undergoing major abdominal surgery, demonstrating that the higher MAP target reduced major organ dysfunction (38.1% vs 48.9%, P=0.006), primarily through decreased acute kidney injury.
The standard threshold of MAP <65 mmHg defines intraoperative hypotension (IOH) across multiple recent studies 2, 3, establishing this as the critical hemodynamic parameter being monitored and optimized.
Alternative Hemodynamic Parameters Studied
While MAP remains primary, other parameters have been investigated as secondary optimization targets:
Cardiac Index-Guided Therapy: The PELICAN trial 4 evaluated individualized cardiac index-guided hemodynamic therapy targeting each patient's preoperative resting cardiac index versus routine hemodynamic therapy in 1,095 high-risk patients. This approach did not improve outcomes (primary composite outcome: 44.3% vs 46.9%, P=0.38), suggesting cardiac index optimization alone is insufficient when used as the primary target.
Flow-Derived vs Predictive Monitoring: Advanced monitoring platforms measure MAP differently but still use it as the primary parameter. The Hypotension Prediction Index (HPI) system was associated with less cumulative IOH duration compared to Vigileo/FloTrac monitoring 2, but both systems fundamentally target MAP maintenance.
Clinical Implications for Hemodynamic Management
For hypertensive patients (age ≥60 with chronic hypertension): Target intraoperative MAP ≥80 mmHg rather than the standard ≥65 mmHg threshold 1. This higher target specifically reduces acute kidney injury risk (23.5% vs 33.7%, P=0.005).
For general high-risk populations: Maintain MAP ≥65 mmHg as the minimum threshold, as distinct hemodynamic phenotypes show graded increases in complications when this threshold is violated 3. Patients with sustained hypotension (phenotype 4) experienced 41.4% AKI rates versus 4.9% in hemodynamically stable patients.
Common Pitfalls
- Avoid relying solely on cardiac index optimization without concurrent MAP management, as the PELICAN trial 4 demonstrated no benefit from this approach alone
- Recognize patient-specific factors: The one-size-fits-all MAP ≥65 mmHg may be inadequate for chronically hypertensive patients who require higher perfusion pressures 1
- Duration matters: Both cumulative hypotension duration and frequency of episodes correlate with outcomes 2, not just isolated measurements